If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

BCRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,023,132.75

BioCryst Pharmaceuticals Insider Trading History Chart

BioCryst Pharmaceuticals Share Price & Price History

^$8.39

▼ -0.17 (-1.99%)

As of 03/30/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

BioCryst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2023	Jon P. Stonehouse	CEO	Sell	100,000	$10.38	$1,038,000.00	1,008,739
12/15/2022	Anthony Doyle	CFO	Sell	5,700	$10.90	$62,130.00	163,966
12/15/2022	Helen M Thackray	Insider	Sell	3,125	$10.89	$34,031.25	133,275
12/15/2022	Jon P. Stonehouse	CEO	Sell	14,100	$10.90	$153,690.00	887,730
12/15/2022	Michael L Jones	Director	Sell	445	$10.90	$4,850.50	10,753
12/2/2022	Jon P. Stonehouse	CEO	Sell	82,656	$12.80	$1,057,996.80	901,830
12/1/2022	Michael L Jones	Director	Sell	8,600	$13.01	$111,886.00	11,198
11/14/2022	Yarlagadda S. Babu	Insider	Sell	31,515	$13.88	$437,428.20	298,541
4/1/2022	Helen M Thackray	Insider	Sell	7,600	$16.20	$123,120.00	136,400
2/15/2022	George B. Abercrombie	Director	Sell	5,000	$18.50	$92,500.00
1/11/2022	Jon P. Stonehouse	CEO	Sell	184,000	$15.04	$2,767,360.00
12/7/2021	Yarlagadda S. Babu	Insider	Sell	30,100	$12.20	$367,220.00
11/24/2021	Vincent Milano	Director	Buy	7,500	$12.19	$91,425.00
11/23/2021	Anthony Doyle	CFO	Buy	35,258	$12.48	$440,019.84
11/15/2021	George B. Abercrombie	Director	Sell	5,000	$12.27	$61,350.00
10/15/2021	Nancy J. Hutson	Director	Sell	105,000	$15.40	$1,617,000.00
9/10/2021	George B. Abercrombie	Director	Sell	74,000	$15.09	$1,116,660.00
7/15/2021	George B. Abercrombie	Director	Sell	5,000	$15.69	$78,450.00	8,000
5/27/2021	William P. Sheridan	Insider	Sell	71,759	$15.00	$1,076,385.00	39,434
5/24/2021	George B. Abercrombie	Director	Sell	6,667	$13.90	$92,671.30	9,667
5/10/2021	George B. Abercrombie	Director	Sell	7,000	$12.70	$88,900.00	3,000
12/11/2020	Alane P. Barnes	VP	Sell	13,741	$7.96	$109,378.36	121,802
12/4/2020	Alane P. Barnes	VP	Sell	13,741	$6.23	$85,606.43	121,802
8/11/2020	Anthony Doyle	CFO	Buy	54,000	$4.08	$220,320.00	54,000

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

79.05% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/27/2023	Neo Ivy Capital Management	16,386	$0.19M	0.1%	N/A	0.009%
3/23/2023	ETF Managers Group LLC	46,478	$0.53M	0.0%	-15.3%	0.025%
3/10/2023	Victory Capital Management Inc.	2,533,584	$29.09M	0.0%	-28.0%	1.344%
2/28/2023	Voya Investment Management LLC	767,015	$8.81M	0.0%	+22.1%	0.411%
2/24/2023	Natixis	4,834	$55K	0.0%	N/A	0.003%
2/16/2023	State of Wyoming	3,031	$35K	0.0%	N/A	0.002%
2/15/2023	Public Employees Retirement System of Ohio	56,067	$0.64M	0.0%	-5.5%	0.030%
2/15/2023	Silverarc Capital Management LLC	272,173	$3.13M	0.9%	+45.9%	0.146%
2/15/2023	State of Wisconsin Investment Board	186,585	$2.14M	0.0%	-1.2%	0.100%
2/15/2023	Sarissa Capital Management LP	980,288	$11.25M	1.3%	-29.5%	0.526%
2/15/2023	Schonfeld Strategic Advisors LLC	21,100	$0.24M	0.0%	-89.9%	0.011%
2/15/2023	Squarepoint Ops LLC	277,741	$3.19M	0.0%	+59.5%	0.149%
2/15/2023	Tang Capital Management LLC	1,450,000	$16.65M	2.4%	+20.8%	0.778%
2/15/2023	Legal & General Group Plc	164,868	$1.89M	0.0%	+0.9%	0.088%
2/15/2023	Lombard Odier Asset Management Switzerland SA	135,062	$1.55M	0.1%	N/A	0.072%
2/15/2023	Mackenzie Financial Corp	21,360	$0.25M	0.0%	-59.4%	0.011%
2/15/2023	Morgan Stanley	1,155,731	$13.27M	0.0%	+27.1%	0.620%
2/15/2023	Nomura Holdings Inc.	1,328,291	$15.22M	0.1%	+368.0%	0.713%
2/15/2023	Norges Bank	1,152,116	$13.23M	0.0%	N/A	0.618%
2/15/2023	Delphia USA Inc.	10,584	$0.12M	0.1%	N/A	0.006%
2/15/2023	E Fund Management Co. Ltd.	40,255	$0.46M	0.0%	+13.7%	0.022%
2/15/2023	Eversept Partners LP	880,487	$10.11M	0.9%	N/A	0.472%
2/15/2023	First Manhattan Co.	1,868,672	$21.45M	0.1%	+3.5%	1.002%
2/15/2023	Algert Global LLC	157,944	$1.81M	0.1%	+62.6%	0.085%
2/15/2023	Alkeon Capital Management LLC	1,485,817	$17.06M	0.1%	+1.4%	0.797%
2/15/2023	Alps Advisors Inc.	126,373	$1.45M	0.0%	+24.5%	0.068%
2/15/2023	AQR Capital Management LLC	24,992	$0.29M	0.0%	+10.8%	0.013%
2/14/2023	Point72 Asset Management L.P.	1,988,627	$22.83M	0.1%	N/A	1.067%
2/14/2023	PDT Partners LLC	60,880	$0.70M	0.1%	-5.1%	0.033%
2/14/2023	Price T Rowe Associates Inc. MD	83,824	$0.96M	0.0%	+2.6%	0.045%
2/14/2023	Moore Capital Management LP	65,000	$0.75M	0.0%	N/A	0.035%
2/14/2023	Two Sigma Advisers LP	1,970,912	$22.63M	0.1%	-2.2%	1.057%
2/14/2023	Two Sigma Investments LP	513,907	$5.90M	0.0%	-50.2%	0.276%
2/14/2023	Pura Vida Investments LLC	106,629	$1.22M	0.1%	-61.5%	0.057%
2/13/2023	Platinum Investment Management Ltd.	134,989	$1.55M	0.1%	-39.1%	0.072%
2/13/2023	Charles Schwab Investment Management Inc.	1,420,387	$16.31M	0.0%	+2.5%	0.762%
2/13/2023	Deutsche Bank AG	109,020	$1.25M	0.0%	+26.4%	0.058%
2/13/2023	Panagora Asset Management Inc.	695,601	$7.99M	0.1%	+38.4%	0.373%
2/13/2023	Wells Fargo & Company MN	9,826	$0.11M	0.0%	-43.0%	0.005%
2/13/2023	Barclays PLC	484,492	$5.56M	0.0%	+17.7%	0.260%
2/13/2023	ExodusPoint Capital Management LP	21,842	$0.25M	0.0%	-96.9%	0.012%
2/13/2023	Credit Suisse AG	252,251	$2.90M	0.0%	+1.1%	0.135%
2/13/2023	Geode Capital Management LLC	3,466,550	$39.80M	0.0%	+3.0%	1.860%
2/13/2023	American Century Companies Inc.	15,142	$0.17M	0.0%	N/A	0.008%
2/13/2023	Teacher Retirement System of Texas	56,078	$0.64M	0.0%	-8.1%	0.030%
2/10/2023	Bank of America Corp DE	986,797	$11.33M	0.0%	+15.4%	0.529%
2/10/2023	Sei Investments Co.	72,410	$0.83M	0.0%	+176.6%	0.039%
2/10/2023	GW&K Investment Management LLC	1,727,087	$19.83M	0.2%	+21.9%	0.926%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	27,796	$0.32M	0.0%	N/A	0.015%
2/10/2023	Victory Capital Management Inc.	2,533,584	$29.09M	0.0%	-28.0%	1.359%
2/10/2023	Franklin Resources Inc.	14,414	$0.17M	0.0%	N/A	0.008%
2/10/2023	Tekla Capital Management LLC	672,705	$7.72M	0.3%	+92.4%	0.361%
2/10/2023	Advisor Group Holdings Inc.	567,918	$6.52M	0.0%	-1.0%	0.305%
2/10/2023	PNC Financial Services Group Inc.	12,220	$0.14M	0.0%	+26.0%	0.007%
2/10/2023	Commerce Bank	14,605	$0.17M	0.0%	+40.8%	0.008%
2/10/2023	Artisan Partners Limited Partnership	2,878,427	$33.04M	0.1%	+8.6%	1.544%
2/9/2023	First Trust Advisors LP	203,634	$2.34M	0.0%	+62.8%	0.109%
2/9/2023	Victory Capital Management Inc.	2,533,398	$29.06M	0.0%	-28.0%	1.359%
2/9/2023	Principal Financial Group Inc.	46,821	$0.54M	0.0%	-54.4%	0.025%
2/9/2023	Citigroup Inc.	341,218	$3.92M	0.0%	-28.1%	0.183%
2/9/2023	Saturn V Capital Management LLC	340,163	$3.75M	3.1%	N/A	0.182%
2/8/2023	Raymond James & Associates	14,734	$0.17M	0.0%	N/A	0.008%
2/8/2023	Skandinaviska Enskilda Banken AB publ	99,086	$1.14M	0.0%	-5.5%	0.053%
2/8/2023	Swiss National Bank	448,968	$5.15M	0.0%	+2.0%	0.241%
2/8/2023	Russell Investments Group Ltd.	150,993	$1.73M	0.0%	+18.7%	0.081%
2/8/2023	Arizona State Retirement System	52,469	$0.60M	0.0%	+4.0%	0.028%
2/7/2023	State Board of Administration of Florida Retirement System	56,271	$0.65M	0.0%	-8.0%	0.030%
2/7/2023	AlphaCentric Advisors LLC	125,000	$1.44M	1.4%	+78.6%	0.067%
2/7/2023	Commonwealth Equity Services LLC	154,699	$1.78M	0.0%	-7.7%	0.083%
2/7/2023	LPL Financial LLC	24,305	$0.28M	0.0%	+10.1%	0.013%
2/7/2023	Handelsbanken Fonder AB	35,500	$0.41M	0.0%	+31.0%	0.019%
2/6/2023	Arete Wealth Advisors LLC	23,623	$271.19B	0.0%	N/A	0.013%
2/3/2023	Fisher Asset Management LLC	4,431,114	$50.87M	0.0%	-14.2%	2.377%
2/2/2023	SG Americas Securities LLC	12,791	$0.15M	0.0%	-40.3%	0.007%
2/2/2023	ProShare Advisors LLC	39,285	$0.45M	0.0%	+8.9%	0.021%
2/1/2023	State of New Jersey Common Pension Fund D	187,999	$2.16M	0.0%	+13.7%	0.101%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	26,667	$0.31M	0.0%	+5.3%	0.014%
1/31/2023	Kestra Advisory Services LLC	21,534	$0.25M	0.0%	+50.4%	0.012%
1/30/2023	New York State Common Retirement Fund	242,965	$2.79M	0.0%	+3.8%	0.130%
1/30/2023	International Assets Investment Management LLC	46,028	$1.40M	0.1%	N/A	0.025%
1/26/2023	Inspire Investing LLC	20,790	$0.24M	0.0%	+26.9%	0.011%
1/24/2023	International Assets Investment Management LLC	46,028	$1.40M	0.3%	N/A	0.025%
1/12/2023	Assenagon Asset Management S.A.	2,590,392	$29.74M	0.1%	-1.0%	1.390%
1/11/2023	North Star Investment Management Corp.	367,300	$4.22M	0.4%	-16.9%	0.197%
12/8/2022	Bank of New York Mellon Corp	671,412	$8.46M	0.0%	+8.3%	0.360%
11/21/2022	California State Teachers Retirement System	232,969	$2.94M	0.0%	-1.7%	0.125%
11/16/2022	Balyasny Asset Management LLC	1,223,721	$15.42M	0.0%	+2.4%	0.656%
11/16/2022	Kingsview Wealth Management LLC	10,277	$0.13M	0.0%	N/A	0.006%
11/16/2022	BNP Paribas Arbitrage SNC	239,880	$3.02M	0.0%	+489.6%	0.129%
11/15/2022	Nomura Holdings Inc.	283,807	$3.57M	0.0%	N/A	0.152%
11/15/2022	WA Asset Management LLC	24,879	$0.31M	0.0%	-16.9%	0.013%
11/15/2022	State Street Corp	9,404,247	$118.49M	0.0%	-14.5%	5.045%
11/15/2022	Public Employees Retirement System of Ohio	59,348	$0.75M	0.0%	N/A	0.032%
11/15/2022	Jacobs Levy Equity Management Inc.	416,526	$5.25M	0.0%	N/A	0.223%
11/15/2022	Algert Global LLC	97,127	$1.22M	0.1%	+24.5%	0.052%
11/15/2022	Twinbeech Capital LP	250,517	$3.16M	0.1%	N/A	0.134%
11/15/2022	Two Sigma Advisers LP	2,015,812	$25.40M	0.1%	-3.2%	1.081%
11/15/2022	Two Sigma Investments LP	1,031,159	$12.99M	0.0%	+325.1%	0.553%
11/15/2022	Trexquant Investment LP	106,470	$1.34M	0.0%	+44.8%	0.057%
11/15/2022	UBS Asset Management Americas Inc.	203,773	$2.57M	0.0%	+1.6%	0.109%

Data available starting January 2016

BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers novel, oral, and small-molecule medicines. The firm focuses on the treatment of rare diseases in which unmet medical needs exist and an enzyme in the biological pathway of the disease. Its programs include BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases, BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva, and galidesivir, a potential treatment for marburg virus disease and yellow fever. The company was founded in 1986 and is headquartered in Durham, NC.

Today's Range

Now: $8.39

$8.31

$8.71

50 Day Range

MA: $9.40

$7.94

$11.01

52 Week Range

Now: $8.39

$7.61

$18.00

Volume

2,021,821 shs

Average Volume

3,030,271 shs

Market Capitalization

$1.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top insider shareholders include:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Anthony Doyle (CFO)
Helen M Thackray (Insider)
William P Sheridan (Insider)
Michael L Jones (Director)
George B Abercrombie (Director)
George B Abercrombie (Director)
Alane P Barnes (Insider)
Nancy J Hutson (Director)
Vincent Milano (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.
Who are the major institutional investors of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top institutional shareholders include:
Fisher Asset Management LLC — 2.38%
Geode Capital Management LLC — 1.86%
Artisan Partners Limited Partnership — 1.54%
Assenagon Asset Management S.A. — 1.39%
Victory Capital Management Inc. — 1.36%
Victory Capital Management Inc. — 1.34%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.
Which major investors are selling BioCryst Pharmaceuticals stock?: During the last quarter, BCRX stock was sold by these institutional investors:
Victory Capital Management Inc.
Victory Capital Management Inc.
Victory Capital Management Inc.
Fisher Asset Management LLC
ExodusPoint Capital Management LP
Two Sigma Investments LP
Sarissa Capital Management LP
Schonfeld Strategic Advisors LLC
Within the previous year, company insiders that have sold BioCryst Pharmaceuticals company stock include:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Anthony Doyle (CFO)
Helen M Thackray (Insider)
William P Sheridan (Insider)
Learn More investors selling BioCryst Pharmaceuticals stock.
Which major investors are buying BioCryst Pharmaceuticals stock?: Within the previous quarter, BCRX stock was bought by institutional investors including:
Point72 Asset Management L.P.
Norges Bank
Nomura Holdings Inc.
Eversept Partners LP
Saturn V Capital Management LLC
Tekla Capital Management LLC
GW&K Investment Management LLC
Tang Capital Management LLC
In the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Learn More investors buying BioCryst Pharmaceuticals stock.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

BCRX Insider Trading

BioCryst Pharmaceuticals Insider Trading History Chart

BioCryst Pharmaceuticals Share Price & Price History

BioCryst Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?

Who are the major institutional investors of BioCryst Pharmaceuticals?

Which major investors are selling BioCryst Pharmaceuticals stock?

Which major investors are buying BioCryst Pharmaceuticals stock?